✦ LIBER ✦

Phase Ib trial of the Toll-like receptor 9 agonist IMO-2055 in combination with 5-fluorouracil, cisplatin, and cetuximab as first-line palliative treatment in patients with recurrent/metastatic squamous cell carcinoma of the head and neck

✍ Scribed by Machiels, Jean-Pascal; Kaminsky, Marie-Christine; Keller, Ulrich; Brümmendorf, Tim H.; Goddemeier, Thomas; Forssmann, Ulf; Delord, Jean-Pierre

Book ID: 125358905
Publisher: Springer US
Year: 2013
Tongue: English
Weight: 333 KB
Volume: 31
Category: Article
ISSN: 0167-6997
DOI: 10.1007/s10637-013-9933-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase 1b Trial of TLR8 Agonist VTX-2337

Phase 1b Trial of TLR8 Agonist VTX-2337 in Combination With Cetuximab in Patients With Recurrent or Metastatic Squamous Cell Carcinomas of the Head and Neck (SCCHN)

✍ Chow, L.Q.M.; Eaton, K.D.; Baik, C.; Goulart, B.; Morishima, C.; Disis, M.L.; Ma 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 74 KB

Phase I/II trial of cilengitide with cet

Phase I/II trial of cilengitide with cetuximab, cisplatin and 5-fluorouracil in recurrent and/or metastatic squamous cell cancer of the head and neck: findings of the phase I part

✍ Vermorken, J B; Guigay, J; Mesia, R; Trigo, J M; Keilholz, U; Kerber, A; Bethe, 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 251 KB

97 Phase I study of cetuximab (C225)in c

97 Phase I study of cetuximab (C225)in combination with cisplatin or carboplatin and 5-fluorouracil (5-FU) in patients (pts) with recurrent and/or metastatic squamous cell carcinoma of the head and neck (R&M SCCHN)

✍ J. Bourhis; F. Rivera; R. Mesia; A. Awada; L. Geoffrois; C. Borel; L. Duck; E. B 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 154 KB

A phase II trial of cisplatin, methotrex

A phase II trial of cisplatin, methotrexate, levofolinic acid, and 5-fluorouracil in the treatment of patients with locally advanced, metastatic squamous cell carcinoma of the head and neck

✍ Francesco Caponigro; Pasquale Comella; Paolo Marcolin; Francesco Russo Spena; Ma 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 2 views

## Background: Induction chemotherapy in locoregionally advanced squamous cell carcinoma of the head and neck (scchn) might improve survival with respect to radiation therapy alone. furthermore, chemotherapy represents the only therapeutic option in metastatic head and neck carcinoma. ## Methods:

A phase II trial of cisplatin, methotrex

A phase II trial of cisplatin, methotrexate, levofolinic acid, and 5-fluorouracil in the treatment of patients with locally advanced, metastatic squamous cell carcinoma of the head and neck

📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 109 KB

Cisplatin and fluorouracil with or witho

Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial

✍ Vermorken, Jan B; Stöhlmacher-Williams, Jan; Davidenko, Irina; Licitra, Lisa; Wi 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 615 KB